Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme

Journal of Neurosurgery

Volumn 84, Issue 2, 1996, Pages 258-263

  Tsurushima, Hideo ^b   Liu, Shu Qin ^b   Tsuboi, Koji ^b   Yoshii, Yoshihiko ^b   Nose, Tadao ^b   Ohno, Tadao ^a  

^a RIKEN   (Japan)

^b NONE

Author keywords

cytotoxic T lymphocyte; glioblastoma multiforme; interferon; interleukin

Indexed keywords

CYTOKINE; INTERFERON;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CARCINOGENESIS; CYTOTOXIC T LYMPHOCYTE; DAUDI CELL; EFFECTOR CELL; GENE INDUCTION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; TARGET CELL;

EID: 13344281026     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.2.0258     Document Type: Article

References (32)

1. Abo T, Balch CM: Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. J Immunol 129:1758-1761, 1982
2. Azuma M, Cayabyab M, Buck D, et al: Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 149:1115-1123, 1992
3. Carrel S, Schmidt-Kessen A, Giuffrè L: Recombinant interferon-γ can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor associated antisens. Eur J Immunol 15: 118-123, 1985
4. De Vries JE, Spits H: Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. in vitro seneration, isolation and analysts of phenotype and specificity. J Immunol 132:510-519, 1984
5. Fisher RI, Coltman CA Jr, Doroshow JH, et al: Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial. Ann Intern Med 108: 518-523, 1988
6. Gillis S, Union NA, Baker PE, et al: The in vitro generation and sustained culture of nude mouse cytoiytic T-lymphocytes. J Exp Med 149:1460-1476, 1979
7. Grimm EA, Mazumder A, Zhang HZ, et al: Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823-1841, 1982
8. 2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci USA 75:6215-6219, 1978
9. Ibayashi Y, Uede T, Uede T, et al: Functional analysis of mononuclear cells infiltrating into tumors: differential cytotoxicity of mononuclear cells from tumors of immune and nonimmune rats. J Immunol 134:648-653, 1985
10. Ioannides CG, Whiteside TL: T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopathol 66:91-106, 1993
11. Kawai K, Sasaki T, Saijo-Kurita K, et al: Additive effects of antirumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay. Cancer Immunol Immunother 35: 225-229, 1992
12. Kedar E, Chriqui-Zeira E, Mitelman S: Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice. Cancer Immunol Immunother 18:126-134, 1984
13. + T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. Cancer Res 51:3891-3899, 1991
14. Liu SQ, Saijo K, Todoroki T, et al: Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Nature Med 1:267-271, 1995
15. Liu SQ, Shiba R, Kim BS, et al: Long-term serum/plasma-free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells. Cancer Immunol Immunother 39:279-285, 1994
16. Mazumder A, Grimm EA, Rosenberg SA, et al: Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin. J Immunol 130:958-964, 1983
17. Mazumder A, Grimm EA, Zhang HZ, et al: Lysis of fresh human solid tumors by autologous lymphocytes activated in virro with lectins. Cancer Res 42:913-918, 1982
18. Miyatake SI, Kikuchi H, Iwasaki K, et al: Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma. J Neurosurg 69:751-759, 1988
19. Mukherji B, Guha A, Chakraborty NG, et al: Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med 169:1961-1976, 1989
20. + cytolytic T lymphocytes. Cell Immunol 155:53-61, 1994
21. Plata F: Specificity studies of cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis by monoclonal cytolytic T lymphocytes. J Exp Med 155: 1050-1062, 1982
22. Roberts TE, Shipton U, Moore M: Role of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones. Int J Cancer 39:436-441, 1987
23. Rosenberg SA, Lotze MT, Muul LM, et al: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Fngl J Med 313:1485-1492, 1985
24. Rosenberg SA, Lotze MT, Muul LM, et al: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889-897, 1987
25. Rosenberg SA, Spiess P, Lafreniere R: A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318-1323, 1986
26. Ryser JE, Cerottini JC, Brunner KT: Generation of cytolytic T lymphocytes in vitro. IX. Induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. J Immunol 120:370-377, 1978
27. Sato T, Sato N, Takahashi S, et al: Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells. Cancer Res 46:4384-4389, 1986
28. Takahashi H, Nakada T, Puisieux I: inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. Science 259:1460-1463, 1993
29. Takahashi T, Ishikura H, Iwai K, et al: Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro. Cancer Immunol Immunother 36:76-82, 1993
30. Topalin SL, Solomon D, Rosenberg SA: Tumor-specific cytolysis by lymphocyte infiltrating human melanomas. J Immunol 142:3714-3725, 1989
31. Wallach D, Fellous M, Revel M: Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299:833-836, 1982
32. Yamasaki T, Handa H, Yamashita J, et al: Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocvte clone for murine malignant gliomas. Cancer Res 44: 1776-1783, 1984